MUCUS RELIEF- guaifenesin 400 mg tablet 
NUVICARE LLC

----------

MUCUS RELIEF- Guaifenesin 400 mg tablet

Active ingredient (in each tablet)

Guaifenesin 400 mg

Purpose

Expectorant

Uses

Warnings

Ask a doctor before use if you have

Stop use and ask a doctor if

If pregnant or breast-feeding,ask a health care professional before use.

KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

Other information

Inactive ingredients

Colloidal Silicon Dioxide, Magnesium Stearate, Microcrystalline Cellulose, Stearic Acid Powder, Sodium Starch Glycolate

Questions or Comments ?

Call 1 (718) 337-8733 or visit: support@nuvicare.com

This product is not manufcatured or distributed by Reckitt Benckiser's , owner of the Registered Trademark MUCINEX®

PL0208-00 NC-Mucus Relief-100ct

MUCUS RELIEF 
guaifenesin 400 mg tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:84324-009
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN400 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  
Product Characteristics
ColorwhiteScoreno score
ShapecapsuleSize17mm
FlavorImprint Code EB
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:84324-009-01100 in 1 BOTTLE; Type 0: Not a Combination Product07/17/2024
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01207/17/2024
Labeler - NUVICARE LLC (119257565)
Registrant - NUVICARE LLC (119257565)

Revised: 7/2024
Document Id: a3ac371b-a205-46c7-b8a8-eb5a245222c3
Set id: e25b440e-f389-443f-b333-c66ad1747158
Version: 1
Effective Time: 20240717
 
NUVICARE LLC